Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives

per Cortellini, Alessio, Dal Mas, Antonella, Cannita, Katia, Collina, Guido, Parisi, Alessandro, Pavese, Francesco, Porzio, Giampiero, Verna, Lucilla, Ficorella, Corrado
Publicat a J Thorac Dis (2018)

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction...

per Bruera, Gemma, Massacese, Silvia, Pepe, Francesco, Malapelle, Umberto, Dal Mas, Antonella, Ciacco, Eugenio, Calvisi, Giuseppe, Troncone, Giancarlo, Simmaco, Maurizio, Ricevuto, Enrico
Publicat a Ther Adv Med Oncol (2019)

Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior In Vitro

per Giusti, Ilaria, D'Ascenzo, Sandra, Mancò, Annalisa, Di Stefano, Gabriella, Di Francesco, Marianna, Rughetti, Anna, Dal Mas, Antonella, Properzi, Gianfranco, Calvisi, Vittorio, Dolo, Vincenza
Publicat 2014

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation

per Napoleoni, Luca, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Dal Mas, Antonella, Calvisi, Giuseppe, Venditti, Olga, Lanfiuti Baldi, Paola, Cocciolone, Valentina, Ricci, Alessandro, Ficorella, Corrado
Publicat a Bioengineering (Basel) (2019)

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of...

per Bruera, Gemma, Cannita, Katia, Di Giacomo, Daniela, Lamy, Aude, Troncone, Giancarlo, Dal Mas, Antonella, Coletti, Gino, Frébourg, Thierry, Sabourin, Jean Christophe, Tosi, Mario, Ficorella, Corrado, Ricevuto, Enrico
Publicat 2012

Intensive multidisciplinary treatment strategies and patient resilience to challenge long-term survival in metastatic colorectal cancer: a case report in real life and clinical pra...

per Bruera, Gemma, Pepe, Francesco, Malapelle, Umberto, Di Staso, Mario, Dal Mas, Antonella, Di Giacomo, Daniela, Scerbo, Gaia, Santilli, Michela, Ciacco, Eugenio, Simmaco, Maurizio, Troncone, Giancarlo, Coco, Claudio, Giuliante, Felice, Ricevuto, Enrico
Publicat a Ann Transl Med (2021)

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

per Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D’Orazio, Carla, Dal Mas, Antonella, Calvisi, Giuseppe, Giordano, Aldo V, Vicentini, Vincenzo, Vicentini, Roberto, Felicioni, Lara, Marchetti, Antonio, Buttitta, Fiamma, Russo, Antonio, Ficorella, Corrado
Publicat a Onco Targets Ther (2019)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations

per Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
Publicat a Oncotarget (2018)

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

per Terrenato, Irene, Arena, Vincenzo, Pizzamiglio, Sara, Pennacchia, Ilaria, Perracchio, Letizia, Buglioni, Simonetta, Ercolani, Cristiana, Sperati, Francesca, Costarelli, Leopoldo, Bonanno, Elena, Baldini, Daniela, Candia, Silvia, Crescenzi, Anna, Dal Mas, Antonella, Di Cristofano, Claudio, Gomes, Vito, Grillo, Lucia Rosalba, Pasquini, Paola, Pericoli, Maria Nicoletta, Ramieri, Maria Teresa, Di Stefano, Domenica, Ruco, Luigi, Scarpino, Stefania, Vitolo, Domenico, d’Amati, Giulia, Paradiso, Angelo, Verderio, Paolo, Mottolese, Marcella
Publicat 2013